Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Cash Earnings per Share (CEPS)

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Cash Earnings per Share (CEPS) History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   CEPS(Rs) -44.2617.0052.4650.1042.28

What is the latest Cash Earnings per Share (CEPS) ratio of GLENMARK PHARMACEUTICALS ?

The latest Cash Earnings per Share (CEPS) ratio of GLENMARK PHARMACEUTICALS is -44.26 based on Mar2024 Consolidated results.
Year Cash Earnings per Share (CEPS)
Mar2024-44.26
Mar202317.00
Mar202252.46
Mar202150.10
Mar202042.28

How is Cash Earnings per Share (CEPS) of GLENMARK PHARMACEUTICALS Trending?

Years Cash Earnings per Share (CEPS) % Change
Mar2024 -44.26
Negative
Mar2023 17
-67.59
Mar2022 52.46
4.71
Mar2021 50.1
18.50
Mar2020 42.28 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Cash Earnings per Share (CEPS) ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹39,503.8 Cr -6.8% -12% 57.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,303.0 Cr -5.1% -9.4% 29.2% Stock Analytics
DIVIS LABORATORIES ₹143,389.0 Cr -7.3% -10.9% 53% Stock Analytics
CIPLA ₹114,645.0 Cr -1.4% -6.7% -1.5% Stock Analytics
DR REDDYS LABORATORIES ₹98,449.5 Cr -9% -14.4% 1.4% Stock Analytics
ZYDUS LIFESCIENCES ₹91,587.4 Cr -7% -5% 22.6% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-6.8%

-12%

57.4%

SENSEX

0.1%

-3.6%

7.9%


You may also like the below Video Courses